CD84 regulates PD-1/PD-L1 expression and function in chronic lymphocytic leukemia

Hadas Lewinsky, Avital F. Barak, Victoria Huber, Matthias P. Kramer, Lihi Radomir, Lital Sever, Irit Orr, Vita Mirkin, Mika Shapiro, Yosef Cohen, Lev Shvidel, Martina Seiffert, Yair Herishanu, Shirly Becker-Herman, Idit Shachar

نتاج البحث: نشر في مجلةمقالةمراجعة النظراء


Chronic lymphocytic leukemia (CLL) is characterized by clonal proliferation and progressive accumulation of mature B lymphocytes in the peripheral blood, lymphoid tissues, and bone marrow. CLL is characterized by profound immune defects leading to severe infectious complications. T cells are numerically, phenotypically, and functionally highly abnormal in CLL, with only limited ability to exert antitumor immune responses. Exhaustion of T cells has also been suggested to play an important role in antitumor responses. CLL-mediated T cell exhaustion is achieved by the aberrant expression of several inhibitory molecules on CLL cells and their microenvironment, prominently the programmed cell death ligand 1/programmed cell death 1 (PD-L1/PD-1) receptors. Previously, we showed that CD84, a member of the SLAM family of receptors, bridges between CLL cells and their microenvironment. In the current study, we followed CD84 regulation of T cell function. We showed that cell-cell interaction mediated through human and mouse CD84 upregulates PD-L1 expression on CLL cells and in their microenvironment and PD-1 expression on T cells. This resulted in suppression of T cell responses and activity in vitro and in vivo. Thus, our results demonstrate a role for CD84 in the regulation of immune checkpoints by leukemia cells and identify CD84 blockade as a therapeutic strategy to reverse tumor-induced immune suppression.
اللغة الأصليةالإنجليزيّة
الصفحات (من إلى)5465-5478
عدد الصفحات14
دوريةJournal of Clinical Investigation
مستوى الصوت128
رقم الإصدار12
المعرِّفات الرقمية للأشياء
حالة النشرنُشِر - 3 ديسمبر 2018


أدرس بدقة موضوعات البحث “CD84 regulates PD-1/PD-L1 expression and function in chronic lymphocytic leukemia'. فهما يشكلان معًا بصمة فريدة.

قم بذكر هذا